Afterward, this tumor-suppressing role was corroborated with other cancers (cutaneous carcinoma, melanoma, lung, cervical, brain, neck, prostate, gastric and renal cancers) and the use of CST6 as a valuable biomarker was confirmed. Here, CST6 is linked to melanoma.